Ascend Wellness Holdings, Inc. splits its revenue into 2 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Retail at $92.7 million, 74% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
488
|
126
|
117
|
121
|
125
|
127
|
128
|
136
|
142
|
| Retail |
345
share 70.6%
|
93
+7.2%
share 73.5%
|
83
-1.5%
share 71.1%
|
—
|
—
|
86
share 67.9%
|
84
share 65.9%
|
—
|
—
|
| Third Party Wholesale |
144
share 29.4%
|
33
-18.2%
share 26.5%
|
34
-22.5%
share 28.9%
|
—
|
—
|
41
share 32.1%
|
44
share 34.1%
|
—
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- AAWH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochelle Park, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1756390
- Former names
- Ascend Wellness Holdings, Inc (until Mar 11, 2022); Ascend Wellness Holdings, LLC (until Apr 15, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.